Fatty liver (i.e., steatosis) is the earliest, most common response that develops in more than 90 percent of drinkers who consume 4–5 standard drinks per day. With continued drinking, alcohol-induced liver disease can proceed to liver inflammation (i.e., steatohepatitis), fibrosis, cirrhosis, and even liver cancer (i.e., hepatocellular carcinoma). The complex interaction of various distinct hepatic cell types is crucial to understand alcohol-mediated liver injury [56,57]. The main events in liver fibrogenesis include activation of stellate cells and production of collagen. The fibrosis that results due to this, determines the extent of damage to the architecture of the liver following chronic alcohol ingestion (Fig. 2). Alcohol abstinence is the linchpin of therapy for AH, since abstinence failure increases mortality rates among those with AH[32].

Then neutrophils and platelets interact with each other, promoting the release of neutrophil extracellular traps to capture and eliminate the microbes [39]. Multiple types of cells in the liver play a role in bacterial phagocytosis and clearance [35]. Liver cells, including Kupffer cells, liver sinusoidal endothelial cells (LSECs), and stellate cells, are the first line of defence against blood-borne bacteria, protecting the whole body and the liver itself. The hepatic reticuloendothelial system traps and eliminates bacteria quickly and efficiently. Kupffer cells exhibit a pronounced endocytic and phagocytic capacity for clearing bacteria and soluble bacterial products [7].

Gut

Current studies suggest a direct interaction between LKB1-AMPK and Rab11a or indirect through Rab11a-Fip1 with constitutive AMPK phosphorylation sites, ensuring apical trafficking (Fu et al. 2011a, 2011b). A combination of ribavirin and peginterferon exhibits rare autoimmune adverse effects in hepatitis C and the effect is severe. The cause of autoimmune adverse effects basically from the inappropriate intake of antiviral drugs and these conditions immediately to seek the specific treatment.

• Patients with decompensated cirrhosis are managed as for any patient with cirrhosis as described below.
• These vacuoles transport the lipid-droplet cargo to lysosomes, where they are degraded by lipid-digesting enzymes (i.e., lipases), releasing free fatty acids that then undergo β-oxidation inside mitochondria.
• These factors attract immune cells (e.g., natural killer [NK] cells and natural killer T cells [NKT cells]) to the liver to exacerbate the inflammatory process.
• However, patients with chronic steatosis are more susceptible to fibrotic liver disease (Teli et al. 1995), because the presence of fat likely represents a greater risk for lipid peroxidation and oxidative damage.
• Fibrates are activators of PPAR \(\alpha\), which coordinates the breakdown of fatty acids.

For example, one recent study showed that presence of severe fibrosis, megamitochondria, degree of neutrophil infiltration, and cholestasis could predict prognosis in patients with AH (60). Many pharmacological agents have been used for treatment alcoholic liver disease of AUD including disulfiram, acamprosate, gabapentin, naltrexone, topiramate, sertraline, and baclofen (41). Of these, only baclofen, a γ-amino butyric acid-B receptor agonist has been found to be safe in patients with ALD and cirrhosis.

Alcohol abuse is a risk factor for infections

In addition, the Activation of Kupffer cells results in the expression and secretion of various pro-inflammatory, chemoattractant cytokines, including TNF-\(\alpha\), IL-6, and IL-1 \(\beta\) (Wen et al. 2020). However, the secretion of Kupffer cell-derived cytokines also modulates the hepatic metabolic function (Metlakunta et al. 2017). Hepatocytes respond to the inflammatory stimulation through Kupffer cell-derived cytokines, particularly IL6 (Su et al. 2018), by decreasing the iron mobilization into the blood to reduce bacterial nutritional sources. Further, hepatocytes start to secrete acute-phase proteins (APPs) such as C-reactive protein (CRP), which can rise from nearly not detectable plasma levels to 400 mg dL−1 within a few hours upon inflammatory and infectious triggers. CRP and other acute-phase proteins are central regulators of the antimicrobial response by opsonising4 pathogens for macrophages and potentiating immune signals.